Witryna26 sie 2024 · IMU Top 20 Shareholders = 36% of the total equity 1. JP Morgan have … WitrynaHER-Vaxx is a B-cell immuno-therapy designed to treat tumours that over-express the HER-2/neu receptor, such as gastric, breast, ovarian, lung and pancreatic cancers. PD1-Vaxx is a B-cell immuno-therapy which aims to induce the body to produce polyclonal antibodies that block PD-1 signalling, and thus produce an anticancer effect similar to ...
Imugene Limited (ASX:IMU) - Intelligent Investor
Witryna28 cze 2024 · A Top 20 Shareholder List as set out in Listing Rule 4.10.9; and A Distribution Schedule as set out in Listing Rule 4.10.7. ENDS Further Information For further information, please contact Joe Walsh Tom Dukovcic Managing Director Exploration Director Lepidico Ltd Lepidico Ltd Tel: +61 (0)8 9363 7800 WitrynaA substantial shareholder is a person or entity that owns 5% or more of the voting … bitlife job interview answers
Top 20 Shareholders - hummgroup
WitrynaIMU UNATTRACTIVE : Imugene's dividend yield of 0.0% is less than the industry average for pharmaceuticals, biotechnology & life sciences stocks listed on the ASX. Dividend Yield explained Implied Growth 40.7% 11.7% Industry Avg IMU Top 20 Shareholders About the Data Show All Shareholder Distribution As reported in the most recent Annual Report. Substantial Shareholders No Substantial Shareholders for IMU in our database. Shareholders Buying 12 month transaction history compiled from ASX announcements. Witryna24 mar 2024 · Current share price for MSB : $0.925 0.01 (1.07%) Mesoblast Limited (MSB), an ASX-listed company, is an Australian company engaged in the development of regenerative medicine products. The key focus is on research and development of adult Mesenchymal Precursor Cells (MPCs), Mesenchymal Stem Cells (MSCs), Dental … database software is used to